Global Healthcare Study on Hidradenitis Suppurativa

Abroad (travel likely)Recruiting

Conditions

Hidradenitis Suppurativa (HS) · Hidradenitis Suppurativa (Acne Inversa)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Zurich, Zurich, Switzerland
Contact: Study coordinator (Julia-Tatjana Maul, Prof. Dr. med.) · julia-tatjana.maul@usz.ch · +41 76 441 51 09

Study leads

Julia-Tatjana Maul, Prof. Dr. med.
Principal Investigator
University of Zurich

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population

Hidradenitis Suppurativa

Abroad (travel likely)Recruiting

Ancona, Italy · Bari, Italy

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Moderate to Severe Plaque Psoriasis · Psoriatic Arthritis · Axial Spondyloarthritis

Abroad (travel likely)RecruitingPHASE1

Santa Monica, United States · South Miami, United States

A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa

Abroad (travel likely)RecruitingPHASE3

Phoenix, United States · Roseville, United States

An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

Hidradenitis Suppurativa

Abroad (travel likely)RecruitingPHASE3

Caba, Argentina · CABA, Argentina